Jamie Murphy
Comptroller/Controller/Auditor en SIGILON THERAPEUTICS, INC. .
Perfil
Jamie Murphy is currently the Vice President-Finance & Controller at Sigilon Therapeutics, Inc. Prior to this, he worked as a Controller at Zafgen, Inc. and as a Financial Consultant at Larimar Therapeutics, Inc. Mr. Murphy completed his undergraduate degree at Wake Forest University and his graduate studies, including an MBA, at Northeastern University.
Cargos activos de Jamie Murphy
| Empresas | Cargo | Inicio |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - |
Antiguos cargos conocidos de Jamie Murphy.
| Empresas | Cargo | Fin |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| LARIMAR THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - |
Formación de Jamie Murphy.
| Wake Forest University | Undergraduate Degree |
| Northeastern University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| SIGILON THERAPEUTICS, INC. | Health Technology |
| LARIMAR THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Jamie Murphy
